Logo
x

Search category

Subscribe Now

Late Onset Pompe Disease

Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) Receives the US FDA's Approval for the Treatment of Late-Onset Pompe Disease

Sanofi's Nexviazyme (avalglucosidase alfa-ngpt) Receives the US FDA's Approval for the Treatment of Late-Onset Pompe Disease

  • August 9, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.